Comparative Study of Cytotoxic and Membranotropic Properties of Betulinic Acid-F16 Conjugate on Breast Adenocarcinoma Cells (MCF-7) and Primary Human Fibroblasts
Authors:
- Konstantin N. BelosludtsevKonstantin N. Belosludtsev
- Anna I. IlzorkinaAIAnna I. Ilzorkina
- Natalia V. BelosludtsevaNatalia V. Belosludtseva
- Vyacheslav A. SharapovVSVyacheslav A. Sharapov
- Nikita V. PenkovNPNikita V. Penkov
- Dmitriy A. SerovDSDmitriy A. Serov
- Maxim N. KaragyaurMKMaxim N. Karagyaur
- Darya A. NedopekinaDNDarya A. Nedopekina
- Eldar V. DavletshinEDEldar V. Davletshin
- Marina E. SolovievaMSMarina E. Solovieva
- Anna Yu SpivakAnna Yu Spivak
- Ulyana Sh. KuzminaUKUlyana Sh. Kuzmina
Open Access
- 11 November 2022
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 10 (11) , 2903
Abstract
The present study evaluates the cytotoxicity of a previously synthesized conjugate of betulinic acid (BA) with the penetrating cation F16 on breast adenocarcinoma (MCF-7) and human fibroblast (HF) cell lines, and also shows the mechanism underlying its membranotropic action. It was confirmed that the conjugate exhibits higher cytotoxicity compared to native BA at low doses also blocking the proliferation of both cell lines and causing cell cycle arrest in the G0/G1 phase. We show that the conjugate indeed has a high potential for accumulation in mitochondria, being visualized in these organelles, which is most pronounced in cancer cells. The effect of the conjugate was observed to be accompanied by ROS hyperproduction in both cancerous and healthy cells, despite the lower base level of ROS in the latter. Along with this, using artificial liposomes, we determined that the conjugate is able to influence the phase state of lipid membranes, make them more fluid, and induce nonspecific permeabilization contributing to the overall cytotoxicity of the tested agent. We conclude that the studied BA–F16 conjugate does not have significant selective cytotoxicity, at least against the studied breast cancer cell line MCF-7.Keywords
Funding Information
- Russian Foundation for Basic Research (20-015-00124, 122041400169-2)
- research plan of the IBG UFRC RAS (20-015-00124, 122041400169-2)
This publication has 32 references indexed in Scilit:
- Synthesis of lupane triterpenoids with triphenylphosphonium substituents and studies of their antitumor activityRussian Chemical Bulletin, 2013
- Mitochondria and cancerNature Reviews Cancer, 2012
- Tehranolide inhibits proliferation of MCF-7 human breast cancer cells by inducing G0/G1 arrest and apoptosisFree Radical Biology and Medicine, 2012
- First self-assembly study of betulinic acid, a renewable nano-sized, 6-6-6-6-5 pentacyclic monohydroxy triterpenic acidNanoscale, 2011
- TriterpenoidsNatural Product Reports, 2009
- ChemInform Abstract: Microwave-Assisted Solvent-Free Synthesis of Some Dimethine Cyanine Dyes, Spectral Properties and TD-DFT/PCM Calculations.ChemInform, 2008
- Microwave-assisted Solvent-free Synthesis of Some Dimethine Cyanine Dyes, Spectral Properties and TD-DFT/PCM CalculationsBulletin of the Korean Chemical Society, 2007
- The function of terpene natural products in the natural worldNature Chemical Biology, 2007
- Pharmacological activities of natural triterpenoids and their therapeutic implicationsNatural Product Reports, 2006
- Investigations on the Steroidal Anti-Inflammatory Activity of Triterpenoids fromDiospyros leucomelas*Planta Medica, 1995